Sail Biomedicines
mRNA and RNA therapeutic delivery platform
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 38 pending · first 2024
- Rank in peer group#59 of 342
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 342 peers
Line = medianBiotech · Platform
- Granted patents#59 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 40- GrantedFused Imidazole Derivatives as AHR AntagonistsUSPTOUS 12,570,638
- PendingNovel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The SameUSPTOApplication 19107348
- PendingComplex Lipid Nanoparticles Encapsulating Polypeptides And Uses ThereofUSPTOApplication 18862799
Show all 40 patent records
- Fused Imidazole Derivatives as AHR AntagonistsMar 10, 2026 · US 12,570,638Granted
- Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The SameMar 5, 2026 · Application 19107348Pending
- Complex Lipid Nanoparticles Encapsulating Polypeptides And Uses ThereofSep 25, 2025 · Application 18862799Pending
- Mrna Vaccine CompositionSep 25, 2025 · Application 18703109Pending
- Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The SameJun 26, 2025 · Application 18850325Pending
- Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The SameFeb 13, 2025 · Application 18710109Pending
- Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The SameFeb 13, 2025 · Application 18712100Pending
- A Bacteria-derived Lipid Composition And Use ThereofJan 2, 2025 · Application 18712576Pending
- Decarboxylase Inhibitors For Treating Parkinson's DiseaseDec 10, 2024 · US 12,162,902Granted
- Biomarkers Related to Immune Checkpoint Inhibitor Therapy and Methods of Using the SameNov 30, 2023 · Application 18248123Pending
- Pyridopyrimidinone Derivatives As Ahr AntagonistsSep 21, 2023 · Application 17756243Pending
- Fused Azole Heterocycles as AHR AntagonistsJul 27, 2023 · Application 17999443Pending
- Mrna Therapeutic CompositionsApplication 18721328Pending
- Rna Therapeutic CompositionsApplication PCTUS2024025331Pending
- Vaccine CompositionsApplication PCTUS2024025270Pending
- Delivery Of PolynucleotidesApplication PCTUS2024025134Pending
- Reduction of Immunogenicity of Circular PolyribonucleotidesApplication 63557158Pending
- Photoreactive Compositions And Methods For Producing Circular PolyribonucleotidesApplication 63551862Pending
- Capped Circular Nucleic Acid MoleculesApplication PCTUS2026015322Pending
- Immune Cell Receptor Therapeutic Compositions And Uses ThereofApplication PCTUS2026011169Pending
- Lipid Compounds, Lipid Nanoparticle Compositions And Use Thereof With PolyribonucleotidesApplication PCTUS2026010824Pending
- Compositions And Methods For Purifying PolyribonucleotidesApplication PCTUS2025061659Pending
- Lipid Compounds, Lipid Nanoparticle Compositions And Use Thereof With PolyribonucleotidesApplication 63900184Pending
- Immune Cell Receptor Therapeutic Compositions And Uses ThereofApplication 63895803Pending
- Immune Cell Receptor Therapeutic Compositions And Uses ThereofApplication 63884924Pending
- Compositions And Methods For Purifying PolyribonucleotidesApplication 63855909Pending
- Rna Compositions Comprising Lipid Nanoparticles Or Lipid Reconstructed Natural Messenger PacksApplication 19127869Pending
- Immune Cell Receptor Therapeutic Compositions And Uses ThereofApplication 63790582Pending
- Capped Circular Nucleic Acid MoleculesApplication 63758629Pending
- Immune Cell Receptor Therapeutic Compositions And Uses ThereofApplication 63744716Pending
- Lipid Compounds, Lipid Nanoparticle Compositions And Use Thereof With PolyribonucleotidesApplication 63744106Pending
- Methods Of Purifying PolyribonucleotidesApplication 63741563Pending
- Engineered PD-1 LigandsApplication 63617869Pending
- Circular Polyribonucleotides Encoding Glucagon-like Peptide (GLP-1) And Uses ThereofApplication 63614238Pending
- Circular Polyribonucleotides Encoding Glucagon-like Peptide (GLP-2) And Uses ThereofApplication 63614264Pending
- Circular Polyribonucleotides Encoding Glucagon-likepeptide (GLP-2) And Uses ThereofApplication 63600527Pending
- Circular Polyribonucleotides Encoding Glucagon-likepeptide (GLP-1) And Uses ThereofApplication 63600503Pending
- Rna CompositionsApplication PCTUS2023037077Pending
- Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The SameApplication PCTUS2023031669Pending
- Complex Lipid Nanoparticles Encapsulating Polypeptides And Uses ThereofApplication PCTUS2023021094Pending
Related companies, and why
- Delix TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Magenta TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Vor BiopharmaSimilar federal contract value in Biotech · null in contracts
- REMD BIOTHERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Tavo BiotherapeuticsSimilar federal contract value in Biotech · null in contracts
- TEAMEDON INTERNATIONAL, INC.Similar federal contract value in Biotech · null in contracts
Press
J&J pays Sail $785M, charting course to possible in vivo CAR-T buyoutFierceBiotech
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .